Tau’s binding factor Pin1, a mitotic regulator overexpressed in cancer and depleted in Alzheimer’s disease (AD), also plays a role in the activation of nuclear deadenylation. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.